Treatment of plaque‐type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol

References

• Kragballe K. Calcipotriol: A new drug for topical psoriasis treatment. Pharmacol Toxicol 1995; 77: 241–246
   PubMedGoogle Scholar
• Schmitt J, Meurer M. [Combined topical therapy of psoriasis: Position of calcitriol and vitamin D analogs]. Hautarzt 2006; 57: 679–684
   PubMedGoogle Scholar
• Storbeck K, Holzle E, Schurer N, Lehmann P, Plewig G. Narrow‐band UVB (311 nm) versus conventional broad‐band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993; 28: 227–231
   PubMed Web of Science ®Google Scholar
• Rodewald EJ, Housman TS, Mellen BG, Feldman SR. The efficacy of 308 nm laser treatment of psoriasis compared to historical controls. Dermatol Online J 2001; 7: 4
   PubMedGoogle Scholar
• Rodewald EJ, Housman TS, Mellen BG, Feldman SR. Follow‐up survey of 308‐nm laser treatment of psoriasis. Lasers Surg Med 2002; 31: 202–206
   PubMed Web of Science ®Google Scholar
• Novak Z, Bonis B, Baltas E, Ocsovszki I, Ignacz F, Dobozy A, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow‐band ultraviolet B. J Photochem Photobiol B 2002; 67: 32–38
   PubMed Web of Science ®Google Scholar
• Bianchi B, Campolmi P, Mavilia L, Danesi A, Rossi R, Cappugi P. Monochromatic excimer light (308 nm): An immunohistochemical study of cutaneous T cells and apoptosis‐related molecules in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 408–413
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceutical Products for Human Use. ICH Harmonized Tripartite Guideline, ‘Guideline for Good Clinical Practice’. Recommended for adoption at Step 4 of the ICH Process on 1 May 1996.
   Google Scholar
• International Conference on Harmonisation of Technical Requirements for the Registrationof Pharmaceutical Products for Human Use. ICH Harmonized Tripartite Guideline, ‘Clinical Data Safety Management: Definitions and Standards for Expedited Reporting’. Recommended for adoption at Step 4 of the ICH Process on 27 May 1994.
   Google Scholar
• Declaration of Helsinki. Guiding Physicians in Biomedical Research Involving Human Subjects. Adopted by the 18th World Medical Assembly, Helsinki (Finland), June 1964. Last amendment by the 48th General Assembly, Somerset West (Republic of South Africa), 1996.
   Google Scholar
• Fredriksson T, Lassus A, Salde L. Reproducibility of clinical trials of topical glucocorticosteroids. Int J Dermatol 1983; 22: 536–539
   PubMed Web of Science ®Google Scholar
• Boer J, Smeenk G. Effect of short‐contact anthralin therapy on ultraviolet B irradiation of psoriasis. J Am Acad Dermatol 1986; 15: 198–204
   PubMed Web of Science ®Google Scholar
• McBride SR, Walker P, Reynolds NJ. Optimizing the frequency of outpatient short‐contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: A randomized, within‐patient controlled trial. Br J Dermatol 2003; 149: 1259–1265
   PubMedGoogle Scholar
• Taneja A, Trehan M, Taylor CR. 308‐nm excimer laser for the treatment of psoriasis: Induration‐based dosimetry. Arch Dermatol 2003; 139: 759–764
   PubMedGoogle Scholar
• Berth‐Jones J, Chu AC, Dodd WA, Ganpule M, Griffiths WA, Haydey RP, et al. A multicentre, parallel‐group comparison of calcipotriol ointment and short‐contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992; 127: 266–271
   PubMed Web of Science ®Google Scholar
• Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41: 51–59
   PubMed Web of Science ®Google Scholar
• Carroll CL, Feldman SR, Camacho FT, Balkrishnan R. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 2004; 151: 895–897
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, et al. A comparison of twice‐daily calcipotriol ointment with once‐daily short‐contact dithranol cream therapy: A randomized controlled trial of supervised treatment of psoriasis vulgaris in a day‐care setting. Br J Dermatol 2006; 155: 800–807
   PubMed Web of Science ®Google Scholar
• Hofmann UB, Eggert AA, Brocker EB, Goebeler M. Calcitriol vs. dithranol in combination with narrow‐band ultraviolet B (311 nm) in psoriasis. Br J Dermatol 2003; 148: 779–783
   PubMedGoogle Scholar
• Kemeny L, Bonis B, Dobozy A, Bor Z, Szabo G, Ignacz F. 308‐nm excimer laser therapy for psoriasis. Arch Dermatol 2001; 137: 95–96
   PubMedGoogle Scholar
• He YL, Zhang XY, Dong J, Xu JZ, Wang J. Clinical efficacy of a 308 nm excimer laser for treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed 2007; 23: 238–241
   PubMed Web of Science ®Google Scholar
• Gattu S, Pang ML, Pugashetti R, Malick F, Hong J, Bowers E, et al. Pilot evaluation of supra‐erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis. J Dermatolog Treat 2009; 1–7
   Google Scholar
• Gattu S, Rashid RM, Wu JJ. 308‐nm excimer laser in psoriasis vulgaris, scalp psoriasis, and palmoplantar psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 36–41
   PubMedGoogle Scholar
• Han L, Somani AK, Huang Q, Fang X, Jin Y, Xiang LH, et al. Evaluation of 308‐nm monochromatic excimer light in the treatment of psoriasis vulgaris and palmoplantar psoriasis. Photodermatol Photoimmunol Photomed 2008; 24: 231–236
   PubMed Web of Science ®Google Scholar
• Trott J, Gerber W, Hammes S, Ockenfels HM. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308‐nm excimer laser sessions. Eur J Dermatol 2008; 18: 55–60
   PubMed Web of Science ®Google Scholar
• Asawanonda P, Amornpinyokeit N, Nimnuan C. Topical 8‐methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque‐type psoriasis. J Eur Acad Dermatol Venereol 2008; 22: 50–55
   PubMedGoogle Scholar
• Zakarian K, Nguyen A, Letsinger J, Koo J. Excimer laser for psoriasis: A review of theories regarding enhanced efficacy over traditional UVB phototherapy. J Drugs Dermatol 2007; 6: 794–798
   PubMedGoogle Scholar
• Mavilia L, Mori M, Rossi R, Campolmi P, Puglisi GA, Lotti T. 308 nm monochromatic excimer light in dermatology: Personal experience and review of the literature. G Ital Dermatol Venereol 2008; 143: 329–337
   PubMedGoogle Scholar
• Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol 2011; 64: 936–949
   PubMed Web of Science ®Google Scholar
• Marchetti A, Feldman SR, Kimball AB, Anderson RR, Miller LH, Martin J, et al. Treatments for mild‐to‐moderate recalcitrant plaque psoriasis: Expected clinical and economic outcomes for first‐line and second‐line care. Dermatol Online J 2005; 11: 1
   PubMedGoogle Scholar
• Nguyen T, Gattu S, Pugashetti R, Koo J. Practice of phototherapy in the treatment of moderate‐to‐severe psoriasis. Curr Probl Dermatol 2009; 38: 59–78
   PubMedGoogle Scholar
• de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, et al. A comparison of twice‐daily calcipotriol ointment with once‐daily short‐contact dithranol cream therapy: Quality‐of‐life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day‐care setting. Br J Dermatol 2008; 158: 375–381
   PubMed Web of Science ®Google Scholar